+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Heat Biologics Inc - logo

Heat Biologics is a biopharmaceutical company that develops novel allogeneic off-the-shelf cellular therapeutic vaccines for a range of cancers and infectious diseases in the United States. It is focused on developing its proprietary "ImPACT" (Immune Pan-Antigen Cytotoxic Therapy), a cell-based immunotherapy for use in the treatment of a wide range of cancers. Heat is currently conducting multiple clinical trials in two indications with its ImPACT therapy based products. The company was founded in 2008 and is based in Durham, North Carolina.

From
From
From
Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2018 - Product Thumbnail Image

Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2018

  • Clinical Trials
  • March 2018
  • 3085 Pages
From
Non-Small Cell Lung Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Non-Small Cell Lung Cancer - Pipeline Review, H1 2018

  • Drug Pipelines
  • June 2018
  • 3034 Pages
From
Heart Transplant Rejection - Pipeline Review, H2 2019 - Product Thumbnail Image

Heart Transplant Rejection - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 35 Pages
From
From
From
Endoplasmin - Pipeline Review, H1 2020 - Product Thumbnail Image

Endoplasmin - Pipeline Review, H1 2020

  • Drug Pipelines
  • February 2020
  • 52 Pages
From
Global Immunotherapy Drugs 2016-2020 - Product Thumbnail Image

Global Immunotherapy Drugs 2016-2020

  • Report
  • March 2016
  • 159 Pages
From
Cancer Vaccines: Technologies and Global Markets - Product Thumbnail Image

Cancer Vaccines: Technologies and Global Markets

  • Report
  • November 2016
  • 183 Pages
From
From
From
From
From
From
From
Colorectal Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Colorectal Cancer - Pipeline Review, H1 2018

  • Drug Pipelines
  • June 2018
  • 2237 Pages
From
Loading Indicator
adroll